Position history for VIKING GLOBAL INVESTORS LP's holdings in Inhibrx Biosciences, Inc.
VIKING GLOBAL INVESTORS LP holds 1.4M shares of INBX (Inhibrx Biosciences, Inc.), worth $113.6M as of 2025-Q4. The position was decreased (-19.6% shares). INBX represents 0.3% of VIKING GLOBAL INVESTORS LP's portfolio.
Current Value
$113.6M
Current Shares
1.4M
Total Value Change
+$88.2M
Total Shares Change
-350,000
Other major holders of INBX: MORGAN STANLEY, HighTower Advisors, LLC, BlackRock, Inc., VANGUARD GROUP INC, Capital Research Global Investors
Decreased |
| 1.4M |
-19.6% |
| $113.6M |
| 0.3% |
| $77.98 |
0 |
| 2025-Q3 | Unchanged | 1.8M | 0.0% | $60.2M | 0.2% | $32.31 | 0 |
| 2025-Q2 | Unchanged | 1.8M | 0.0% | $25.5M | 0.1% | $14.43 | 0 |
| 2025-Q1 | Unchanged | 1.8M | 0.0% | $25M | 0.1% | $14.12 | 0 |
| 2024-Q4 | Unchanged | 1.8M | 0.0% | $27.5M | 0.1% | $15.14 | 0 |
| 2024-Q3 | Unchanged | 1.8M | 0.0% | $28M | 0.1% | $15.52 | 0 |
| 2024-Q2 | New | 1.8M | - | $25.3M | 0.1% | $14.17 | 40 |